Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C

被引：0
|
作者：
Jacobs, RJ [1 ]
Koff, RS
机构：
[1] Capitol Outcomes Res Inc, Alexandria, VA USA
[2] Univ Massachusetts, Sch Med, Boston, MA 02125 USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：873 / 874
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of Hepatitis A vaccination in a developed and developing country
    Ghildayal, Nidhi
    [J]. INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2019, 32 (08) : 1175 - 1199
  • [42] Cost-effectiveness of hepatitis A and B vaccination programme in Germany
    Szucs, T
    [J]. VACCINE, 2000, 18 : S86 - S89
  • [43] Cost-effectiveness analysis of hepatitis A vaccination strategies for adults
    O'Connor, JB
    Imperiale, TF
    Singer, ME
    [J]. HEPATOLOGY, 1999, 30 (04) : 1077 - 1081
  • [44] Cost-effectiveness of hepatitis B vaccination of prison inmates
    Pisu, M
    Meltzer, MI
    Lyerla, R
    [J]. VACCINE, 2002, 21 (3-4) : 312 - 321
  • [45] ESTIMATING THE COST-EFFECTIVENESS OF DACLATASVIR REGIMENS FOR PATIENTS WITH ADVANCED CHRONIC HEPATITIS C IN THE UK
    McEwan, P.
    Webster, S.
    Ward, T.
    Kalsekar, A.
    Yuan, Y.
    Brenner, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A239 - A239
  • [46] Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
    Camma, Calogero
    Petta, Salvatore
    Enea, Marco
    Bruno, Raffaele
    Bronte, Fabrizio
    Capursi, Vincenza
    Cicchetti, Americo
    Colombo, Giorgio L.
    Di Marco, Vito
    Gasbarrini, Antonio
    Craxi, Antonio
    [J]. HEPATOLOGY, 2012, 56 (03) : 850 - 860
  • [47] Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
    Lin, OS
    Keeffe, EB
    Sanders, GD
    Owens, DK
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (11) : 1159 - 1172
  • [48] Treatment of patients with chronic hepatitis C: Doubts about a cost-effectiveness study - Response
    Joliot, E
    Vanlemmens, C
    Miguet, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (04): : 337 - 338
  • [49] Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis
    Chan, Jocelyn
    Kim, John J.
    Barrett, Brett K.
    Hamadeh, Abdullah
    Feld, Jordan J.
    Wong, William W. L.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2021, 28 (02) : 260 - 267
  • [50] COST-EFFECTIVENESS OF SOFOSBUVIR AND LEDIPASVIR IN THE TREATMENT OF PATIENTS WITH HEPATITIS C
    Leleu, H.
    Blachier, M.
    Hauvespre, A.
    Pentel, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A585 - A585
12345